Clinical Trials for Mesothelioma Patients—A Study of Carboplatin, Bevacizumab and Pemetrexed for MPM Patients: Contacts

Read about the contacts for a current clinical trial about the use of Carboplatin, Bevacizumab and Pemetrexed for MPM patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Contacts:
Contact: Melissa Joiner, R.N.
813-745-1896
melissa.joiner@moffitt.org
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States, 33612
Principal Investigator: Roohi Ismail-Khan, M.D.
Principal Investigator: George Simon, M.D.
Sub-Investigator: Scott Antonia, M.D.
Sub-Investigator: Gerold Bepler, M.D.
Sub-Investigator: Alberto Chiappori, M.D.
Sub-Investigator: Lynn Coppage, M.D.
Sub-Investigator: Eric Haura, M.D.
Sub-Investigator: Todd Hazelton, M.D.
Sub-Investigator: Tawee Tanvetyanon, M.D.
Sub-Investigator: Charles Williams, M.D.

If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.